GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pure Biologics SA (WAR:PUR) » Definitions » Days Sales Outstanding

Pure Biologics (WAR:PUR) Days Sales Outstanding : 9,687.71 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Pure Biologics Days Sales Outstanding?

Pure Biologics's average Accounts Receivable for the three months ended in Mar. 2024 was zł0.32 Mil. Pure Biologics's Revenue for the three months ended in Mar. 2024 was zł0.00 Mil. Hence, Pure Biologics's Days Sales Outstanding for the three months ended in Mar. 2024 was 9,687.71.

The historical rank and industry rank for Pure Biologics's Days Sales Outstanding or its related term are showing as below:

WAR:PUR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.42   Med: 53.03   Max: 1682.17
Current: 1682.17

During the past 8 years, Pure Biologics's highest Days Sales Outstanding was 1682.17. The lowest was 8.42. And the median was 53.03.

WAR:PUR's Days Sales Outstanding is ranked worse than
96.51% of 888 companies
in the Biotechnology industry
Industry Median: 72.34 vs WAR:PUR: 1682.17

Pure Biologics's Days Sales Outstanding increased from Mar. 2023 (741.01) to Mar. 2024 (9,687.71).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


Pure Biologics Days Sales Outstanding Historical Data

The historical data trend for Pure Biologics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Biologics Days Sales Outstanding Chart

Pure Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 46.96 65.41 50.30 56.24 851.03

Pure Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 741.01 31,116.25 515.73 2,854.10 9,687.71

Competitive Comparison of Pure Biologics's Days Sales Outstanding

For the Biotechnology subindustry, Pure Biologics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pure Biologics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pure Biologics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Pure Biologics's Days Sales Outstanding falls into.



Pure Biologics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Pure Biologics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.151 + 0.292) / 2 ) / 0.095*365
=0.2215 / 0.095*365
=851.03

Pure Biologics's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0.292 + 0.345) / 2 ) / 0.003*365 / 4
=0.3185 / 0.003*365 / 4
=9,687.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pure Biologics  (WAR:PUR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Pure Biologics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Pure Biologics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Pure Biologics (WAR:PUR) Business Description

Traded in Other Exchanges
Address
ul. Dunska 11, Wroclaw, POL, 54-427
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

Pure Biologics (WAR:PUR) Headlines

No Headlines